Identification of chromosomal abnormalities in miscarriages using single-nucleotide polymorphism arrays Authors: Wantong Zhao, Haiwei Wang, Bin Liang, Hailong Huang, Na Lin, Liangpu Xu Published: 2026 ABSTRACT AbstractPurposeChromosome abnormalities are a known cause of miscarriage. A detailed chromosomal study in miscarriages is delineated using high-throughput technologies.Methods564 miscarriages were collected, and the chromosomal abnormalities, including triploidy, trisomy, monosomy, uniparental disomy, and chromosomal deletions/duplications in miscarriages, were detected by high-throughput single-nucleotide polymorphism (SNP) array.ResultsThere were 336 (59.6%) miscarriages with chromosomal abnormalities, including 325 (57.6%) miscarriages with pathogenic variants and 11 (2%) miscarriages with variations of unknown significance (VOUS). The remaining 228 (40.4%) miscarriages had no clinically relevant chromosomal variants. Among the 325 miscarriages with pathogenic variants, 23 miscarriages had triploidy and two miscarriages showed genome-wide uniparental disomy. Trisomy was found in 225 miscarriages and involved nearly every chromosome. Monosomy X was found in 39 miscarriages. Also, 32 miscarriages were with partial chromosomal deletions/duplications, particularly in 8p23 and Xp22 regions.ConclusionsOur results confirmed that trisomy and monosomy X are potentially the most common causes of miscarriage. We also showed that chromosomal pathogenic deletions/duplications are involved with miscarriage. However, still nearly 40% of miscarriages had no chromosomal variants detected by SNP array. This may be attributed to a single gene mutation that requires high-throughput sequencing.Keywords: Miscarriage, Chromosomal abnormality, SNP array, Pathogenic copy number variation, Trisomy What does this study add to the clinical work This article reflects that trisomy and monosomy X are the most common cause of miscarriage. Nearly 40% miscarriages could not be explained by chromosomal variants which require other high-throughput sequencing. Introduction Miscarriage affects more than 10–15% of all pregnant women and is increasing every year [1]. Air pollution, X-ray exposure, and long-term secondhand smoking exposure are risk factors of miscarriage [2]. Maternal factors, like age, germ cell deformity, uterine disease, and immune system deficits, are also associated with the pathogenesis of miscarriage [3, 4]. However, genetic alterations remain the most important pathological causes of miscarriage. Chromosomal abnormalities are the most common cause of miscarriage. More than 50% of cases of miscarriage are due to chromosomal abnormalities [5]. Chromosomal aneuploidies, which lead to cell growth arrest, are found in some miscarriages [6]. However, chromosomal abnormalities are diverse, including aneuploidies, chromosomal copy number variations (CNVs), structural rearrangements, and so on. Different types of chromosomal abnormalities may affect embryonic development differently [7]. Hence, it is critical to determine the types of chromosomal abnormalities in miscarriage and study the parental karyotypes when appropriate to identify familial rearrangements. Single-nucleotide polymorphism (SNP) array and CNV sequencing are currently two mainstream techniques used in clinical settings for detecting chromosomal CNVs. SNP array experiment is relatively mature and has undergone years of clinical validation [8]. In this study, we detected the chromosomal abnormalities in 564 miscarriages using SNP array. We found that 325 (57.6%) miscarriages had chromosomal abnormalities, including triploidy, trisomy, genome-wide uniparental disomy (UPD), chromosomal deletions, and chromosomal duplications. However, 228 (40.4%) miscarriages had no clinically relevant chromosomal variants and should be further studied using other techniques, like whole-exome sequencing and whole-genome sequencing. Materials and methods Patients A total of 564 pregnant women were diagnosed with miscarriage by Doppler ultrasound examination and aborted at Fujian Maternity and Child Health Hospital from 2016 to 2022. Chorionic villi, amniotic fluid, and skin tissues from pregnant women or aborted miscarriages were collected for further SNP array. Written informed consents of SNP arrays and prenatal diagnosis from pregnant women were obtained. This study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Ethics Committee of Fujian Maternal and Child Health Hospital (ID:2024KY139). SNP array experiment and prenatal diagnosis Fundamental principles of SNP array are that DNA fragments are hybridized with known, fixed DNA probes on the chip, and the copy number is determined based on fluorescence signal intensity. Before the SNP array experiments, maternal cell contamination was tested. All samples with maternal cell contamination were not further used in SNP array experiments. Basically, fetal DNA samples were extracted from chorionic villi, amniotic fluid, and skin tissues using QIAGEN DNA Mini Kit (Qiagen, Valencia, CA, USA). DNA was digested, amplified, purified, fragmented, labeled, and hybridized according to the standard Affymetrix protocols. SNP array experiments were carried out using CytoScan 750 K platform and scanned with GeneChip Scanner 3000 system (Affymetrix Inc., Santa Clara, CA, USA). Raw CEL data were annotated using hg19 genome version and converted into CYCHP form using Chromosome Analysis Suite (ChAS). Chromosomal abnormalities were further analyzed using ChAS. During prenatal diagnosis, the variants were divided into pathogenic, likely pathogenic, variants of unknown significance (VOUS), likely benign and benign [9, 10] using Online Mendelian Inheritance in Man (OMIM, http://www.omim.org) database, Database of Genomic Variants (DGV, http://projects.tcag.ca/variation), and Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources (DECIPHER, https://decipher.sanger.ac.uk). B allele frequencies were noted either as AA, BB, AB, A, or B with long stretches of either AA or BB interpreted as Absence of Heterozygosity (AOH) and regions of either A or B interpreted as deletion. Statistical analysis Statistical analysis was carried out using Student’s t test. A P value less than 0.05 was chosen to be significantly different. * P < 0.05 and ** P < 0.01 were shown. Results SNP array analysis of 564 pregnant women with miscarriage In total, 564 samples including 542 chorionic villi and five amniotic fluid samples were collected from pregnant women diagnosed with miscarriage. In addition, 17 skin tissues from aborted fetuses were obtained (Table 1). After SNP analysis and prenatal diagnosis, 325 (57.6%) miscarriages were found to carry chromosomal pathogenic variants or likely pathogenic variants. CNV was determined as a variation in DNA copy number greater than 100 kb (resolution of SNP array), without whole chromosomal trisomy or monosomy. However, 228 (40.4%) miscarriages had no clinically relevant chromosomal variants. In addition, 11 (1.95%) miscarriages had chromosomal variants of unknown significance (VOUS) (Table 1). Table 1Prenatal diagnosis of 564 pregnant women with miscarriagesSamples for SNP arrayChorionic villusAmniotic fluidTissueNumber of samples (564)542517Prenatal diagnosisNo clinical variationsPathogenic variantsVariants of unknown significance (VOUS)Number of samples (564)22832511Maternal age(Years ± SEM)30.28 ± 0.29831.97 ± 0.26*33.8 ± 1.34** Prenatal diagnosis of 564 pregnant women with miscarriages Maternal age (Years ± SEM) Maternal age was a risk factor in the pregnant process. Advanced maternal age is associated with eclampsia, intracranial hemorrhage, birth defects, congenital heart disease, and miscarriage [11]. Compared with miscarriages without clinically relevant chromosomal variants, maternal age was higher in miscarriages with chromosomal pathogenic variants (P < 0.05) (Table 1). Also, the maternal age was higher in miscarriages with VOUS (P < 0.01) (Table 1). The mean maternal age with chromosomal pathogenic variants or with VOUS was 31.97 ± 0.26 and 33.8 ± 1.34, respectively, while the mean maternal age without clinically relevant chromosomal variants was 30.28 ± 0.298 (Table 1). Moreover, the abnormality rate in the maternal age < 30 abnormality rate group was 51.4%, and this rate was increased to 57.9% in the maternal age 30–34 years old group, while the maternal age 35–39 years old group had the highest abnormality rate that was 71.8%. Chromosomal abnormalities found among 325 miscarriages Chromosomal abnormalities, such as triploidy, trisomy, monosomy, and genome-wide UPD, were all detected in miscarriages by SNP array. UPD can be indicated by absence of heterozygosity (AOH) of the whole chromosome, also known as copy-neutral loss of heterozygosity, which refers to long contiguous stretches of homozygosity in a chromosome [12]. Among the 325 miscarriages with pathogenic variants, chromosomal aneuploidies (including trisomy and monosomy), triploidy, and UPD were found in 268, 32, and two miscarriages, respectively (Table 2). Table 2Chromosomal abnormalities of 325 miscarriages with pathogenic variantsPathogenic variantsTriploidyUniparental disomyTrisomyMonosomyChromosomal deletions or duplicationsNumber of samples (325)2322254332 Chromosomal abnormalities of 325 miscarriages with pathogenic variants Furthermore, trisomies were found for nearly all chromosomes in miscarriages, except chromosome 1. In total, 225 (39.9%) miscarriages had trisomy. The number of miscarriages with different trisomies is shown in Table 3. Briefly, 21 miscarriages had trisomy 13, and 64 miscarriages had trisomy 16. Trisomy 21 was found in 18 miscarriages, and trisomy 22 was found in 37 miscarriages. Nine miscarriages had double trisomy. These results confirm that trisomies, particularly trisomy 16, trisomy 21, and trisomy 22, are the most common causes of miscarriage [13, 14]. Table 3Trisomy in 225 miscarriagesTrisomyNumber of casesarr(2) × 34arr(3) × 35arr(4) × 37arr(5) × 32arr(6) × 32arr(7) × 37arr(8) × 37arr(9) × 35arr(10) × 34arr(11) × 31arr(12) × 31arr(13) × 321arr(14) × 38arr(15) × 38arr(16) × 364arr(17) × 32arr(18) × 37arr(19) × 33arr(20) × 31arr(21) × 318arr(22) × 337arr(X) × 32Double Trisomy9 Trisomy in 225 miscarriages In total, 43 (7.6%) miscarriages had a monosomy (Table 2). Particularly, monosomy X, associated with Turner syndrome, was found in 39 (6.9%) miscarriages [15, 16]. Monosomy 21 was found in three miscarriages, and monosomy involved with 14 chromosomes was found in one miscarriage (Table 2). Chromosomal deletions or duplications identified as pathogenic variants in miscarriages In addition to other chromosome anomalies detected, 32 miscarriages had partial chromosomal deletions or duplications, which were defined as pathogenic variants. The detailed chromosomal deletions or duplications in those 32 miscarriages are presented in Table 4. One case (case 22) had a deletion of 15q11.2 regions involved in 507 kb, and the loss of this region is associated with Burnside–Butler syndrome [17]. It is unclear if this finding contributed to the miscarriage or is coincidental. Table 4Chromosomal deletions/duplications identified as pathogenic variants in 32 miscarriagesCaseRegionsSizeAbnormalitiesOMIM genes1arr[hg19]1p36.33p36.32(849,466–2,579,267) × 3arr[hg19]15q26.1q26.3(94,233,409–102429040) × 11.7 Mb8.2 MbDuplicationdeletion43172arr[hg19]2p25.3(12,771–2,390,639) × 12.4 MbDeletion83arr[hg19]2p25.3p22.2(12,771–37,039,935) × 337 MbDuplication1574arr[hg19]3p26.3p24.3(61,891–23,348,154) × 3arr[hg19]4p16.3q21.21(68,345–81,776,428) × 323.3 Mb81.7 MbDuplicationDuplication872795arr[hg19]4p16.3p15.32(68,345–17,567,960) × 117.5 MbDeletion916arr[hg19]4p16.3p16.1(68,345–8,721,580) × 18.6 MbDeletion707arr[hg19]5p15.33p14.3(113,576–22,823,694) × 122.7 MbDeletion558arr[hg19]5q35.3(179,249,664–180,715,096) × 1 arr[hg19]22q13.2q13.33(41,167,042–51099092) × 31.4 Mb9.9 MbDeletionDuplication331679arr[hg19]6p25.3q13(294,825–75,334,384) × 375 MbDuplication85610arr[hg19]6q21q23.3(109,019,605–136245611) × 2 hmz arr[hg19]14q13.1q23.2(34,585,230–62540298) × 2 hmz27.2 Mb27.9 MbAOHAOH10412611arr[hg19]7q31.2q34(115,729,160–141679588) × 3arr[hg19]7q34q36.3(141,687,274–159,119,707) × 126 Mb17 MbDuplicationDeletion1208812arr[hg19]7q34q36.3(142,342,270–159119707) × 116.7 MbDeletion8613arr[hg19]8p23.3p11.22(158,048–38587551) × 1 arr[hg19]22q13.31q13.33(46,849,180–51072556) × 338.5 Mb4.5 MBDeletionDuplication1572914arr[hg19]8p23.3p11.21(158,048–40469480) × 1arr[hg19] 20p13p12.1(61,661–15,916,956) × 340 Mb15.8 MbDeletionDuplication34316115arr[hg19]8p23.3p12(158,048–33547773) × 133.4 MbDeletion14916arr[hg19]8p23.3p12(158,048–35444027) × 135 MbDeletion15017arr[hg19]8p23.3p21.3(158,049–20344872) × 120.2 MbDeletion7218arr[hg19]8p23.3p23.1(158,048–11935465) × 111.77 MbDeletion4019arr[hg19]8q13.3q24.3(70,949,908–146295771) × 3 arr[hg19]22q13.31q13.33(48,324,664–51,197,766) × 175.3 Mb2.8 MbDuplicationDeletion4874620arr[hg19]9q22.33q33.3(99,889,390–128756159) × 328.8 MbDuplication24121arr[hg19]13q12.12q34(25,196,626–115,107,733) × 389.9 MbDuplication54822arr[hg19]15q11.2(22,770,422–23277436) × 1507 kbDeletion423arr[hg19]15q11.2q25.2(22,770,421–84834123) × 3arr[hg19]15q25.2q26.3(85,053,133–102429040) × 162.06 Mb17.38 MbDuplicationDeletion3947124arr[hg19]16p11.2(29,696,959–30,165,725) × 3469 KbDuplication1925arr[hg19]17p13.3p13.2(525–4,931,704) × 14.9 MbDeletion7826arr[hg19]18p11.32p11.31(136,227–3,230,017) × 1arr[hg19]18p11.31(3,232,702–4446004) × 3arr[hg19]18q12.1q23(29,715,217–78,013,728) × 33.09 Mb1.21 Mb48.3 MbDeletionDuplicationDuplication14312927arr[hg19]18q22.3q23(70,131,935–78013728) × 17.88 MbDeletion2128arr[hg19]Xp22.33p11.1(168,551–58,326,434) × 1 arr[hg19]Xp11.1q28(58,348,173–155,233,098) × 358 Mb96 MbDeletionDuplication30041129arr[hg19]Xp22.33p11.22(168,552–52,092,488) × 1 arr[hg19]Xq13.3q28(75,786,935–155,233,098) × 151.9 Mb79.4 MbDeletionDeletion26536730arr[hg19]Xp22.33p22.12(168,552–19,907,735) × 1arr[hg19]Xp22.12q28(20,116,846–155233098) × 119.3 Mb135 MbDeletionDeletion9864831arr[hg19]Yp11.31p11.2(2,650,424–6356292) × 03.7 MbDeletion632arr[hg19]Yp11.32p11.31(168,551–2,703,942) × 028.6 MbDeletion65hmz homozygosity, AOH Absence of Heterozygosity Chromosomal deletions/duplications identified as pathogenic variants in 32 miscarriages arr[hg19]1p36.33p36.32(849,466–2,579,267) × 3 arr[hg19]15q26.1q26.3(94,233,409–102429040) × 1 1.7 Mb 8.2 Mb Duplication deletion 43 17 arr[hg19]3p26.3p24.3(61,891–23,348,154) × 3 arr[hg19]4p16.3q21.21(68,345–81,776,428) × 3 23.3 Mb 81.7 Mb Duplication Duplication 87 279 1.4 Mb 9.9 Mb Deletion Duplication 33 167 27.2 Mb 27.9 Mb AOH AOH 104 126 arr[hg19]7q31.2q34(115,729,160–141679588) × 3 arr[hg19]7q34q36.3(141,687,274–159,119,707) × 1 26 Mb 17 Mb Duplication Deletion 120 88 38.5 Mb 4.5 MB Deletion Duplication 157 29 arr[hg19]8p23.3p11.21(158,048–40469480) × 1 arr[hg19] 20p13p12.1(61,661–15,916,956) × 3 40 Mb 15.8 Mb Deletion Duplication 343 161 75.3 Mb 2.8 Mb Duplication Deletion 487 46 arr[hg19]15q11.2q25.2(22,770,421–84834123) × 3 arr[hg19]15q25.2q26.3(85,053,133–102429040) × 1 62.06 Mb 17.38 Mb Duplication Deletion 394 71 arr[hg19]18p11.32p11.31(136,227–3,230,017) × 1 arr[hg19]18p11.31(3,232,702–4446004) × 3 arr[hg19]18q12.1q23(29,715,217–78,013,728) × 3 3.09 Mb 1.21 Mb 48.3 Mb Deletion Duplication Duplication 14 3 129 58 Mb 96 Mb Deletion Duplication 300 411 51.9 Mb 79.4 Mb Deletion Deletion 265 367 arr[hg19]Xp22.33p22.12(168,552–19,907,735) × 1 arr[hg19]Xp22.12q28(20,116,846–155233098) × 1 19.3 Mb 135 Mb Deletion Deletion 98 648 hmz homozygosity, AOH Absence of Heterozygosity Moreover, six miscarriages (cases 13–18) had deletions of 8p23 regions, including FBXO25, DLGAP2, CLN8, ARHGEF10, MYOM2, CSMD1, GATA4, and NEIL2 OMIM genes. Reports showed that abnormalities in those regions are potentially associated with miscarriage and intellectual disability [18]. Three miscarriages (cases 28–30) had chromosomal deletions of Xp22 regions. Deletion of these regions can result in heart malformations [19]. Two cases showed genome-wide UPD. This finding may be associated with complete molar pregnancies [20]. Yet, the associations of these regions with miscarriage are unclear and should be further studied. Chromosomal alterations identified as variations of unknown significance (VOUS) in miscarriages Some chromosomal alterations in miscarriages had no known clinical significance and were defined as VOUS. The detailed chromosomal alterations of the 11 miscarriages defined as VOUS are presented in Table 5. In case 1, both 1q44 duplication and mosaic 2q37.2q37.3 deletion were defined as VOUS, which may be an unbalanced rearrangement. For case 3 and cases 5–9, the altered chromosomal regions included large regions of absence of homozygosity (AOH). Currently, there are no clear pathogenic imprinted genes in those regions and were therefore classified as VOUS. Other chromosomal deletions or duplications in miscarriages with VOUS included 1q44, 3p26.3, and 20p13 regions. The associations of those regions with miscarriage are unclear and should be further studied. Table 5Chromosomal alterations identified as VOUS in 11 miscarriagesCaseRegionsSizeAbnormalitiesOMIM genes1arr[hg19]1q44(24,622,131–249,224,684) × 3 arr[hg19]2q37.2q37.3(236,566,319–242,062,162) × 1–23 Mb5.5 MbDuplicationMosaic deletion14342arr[hg19]2p25.3(12,771–2,390,639) × 32.1 MbDuplication83arr[hg19]3p14.2p11.1(59,365,038–90485635) × 2 hmzarr[hg19]3q11.1q13.11(93,558,926–103,243,507) × 2 hmz31 Mb10 MbAOHAOH694arr[hg19]3p26.3(61,891–2,441,042) × 12.38 MbDeletion35arr[hg19] 5q11.1q13.2(49,560,858–68826246) × 2 hmzarr[hg19]5p13.2p11(38,119,461–46,383,335) × 2 hmzarr[hg19]10q11.22q21.1(48,654,362–59,013,629) × 2 hmz arr[hg19]14q32.2q32.33(98,824,485–107,285,437) × 2 hmzarr[hg19]17p12p11.1(13,895,964–22,217,883) × 2 hmz19.26 Mb8.26 Mb10.36 Mb8.46 Mb8.32 MbAOHAOHAOHAOHAOH65272586706arr[hg19]5q11.1q35.3(49,564,628–180,692,321) × 2 hmz130 MbAOH927arr[hg19]5q34q35.3(164,130,490–176629546) × 2 hmz12.5 MbAOH68arr[hg19]9q22.33q33.1(101,944,435–121284276) × 2 hmz19.3 MbAOH799arr[hg19]19p13.2p11(6,939,202–24462369) × 2 hmz17.5 MbAOH4210arr[hg19]20p13(61,662–813,302) × 1752 kbDeletion1011arr[hg19]22q13.2q13.31(43,560,872–44259781) × 3699 kbDuplication3hmz homozygosity, AOH Absence of Heterozygosity Chromosomal alterations identified as VOUS in 11 miscarriages 3 Mb 5.5 Mb Duplication Mosaic deletion 14 34 arr[hg19]3p14.2p11.1(59,365,038–90485635) × 2 hmz arr[hg19]3q11.1q13.11(93,558,926–103,243,507) × 2 hmz 31 Mb 10 Mb AOH AOH 6 9 arr[hg19] 5q11.1q13.2(49,560,858–68826246) × 2 hmz arr[hg19]5p13.2p11(38,119,461–46,383,335) × 2 hmz arr[hg19]10q11.22q21.1(48,654,362–59,013,629) × 2 hmz arr[hg19]14q32.2q32.33(98,824,485–107,285,437) × 2 hmz arr[hg19]17p12p11.1(13,895,964–22,217,883) × 2 hmz 19.26 Mb 8.26 Mb 10.36 Mb 8.46 Mb 8.32 Mb AOH AOH AOH AOH AOH 65 27 25 86 70 hmz homozygosity, AOH Absence of Heterozygosity Discussion Consistent with previous results [5], our analysis showed that chromosomal abnormalities are the most important causes of miscarriage. 57.6% of miscarriages had pathogenic variants. However, still, 42.4% of miscarriages had no clinically relevant chromosomal variants or had variations of unknown significance. Some of the miscarriages may be associated with other maternal risk factors or environmental risk factors. Other cases of miscarriage may be associated with genetic mutations or epigenetic alterations [21] and should be further studied using other techniques like whole-genome sequencing or exome sequencing. Compared with UPD or triploidy, trisomy was the most common chromosomal abnormality found in the miscarriages. Among the 325 miscarriages with pathogenic variants, 69% of miscarriages had trisomy. Particularly, trisomy 13, trisomy 16, trisomy 21, and trisomy 22 were the most common trisomies found. Furthermore, compared with other chromosomal abnormalities, miscarriages with trisomy had higher maternal age and confirmed that with increased maternal age, the risk of miscarriages increases [22]. Deletions of 8p23 regions or Xp22 regions are previously known pathogenic CNVs and are associated with multiple genetic defects. Deletions of 8p23 regions were found in six miscarriages, and deletions of Xp22 regions were found in three female miscarriages. OMIM genes CLN8 and GATA4 in 8p23 regions are associated with embryonic development [23, 24]. However, the detailed associations of those chromosomal regions with miscarriage should be further studied. In addition, cases showing two or more CNVs may warrant further investigation. Fluorescence in situ hybridization (FISH) of the fetal chromosomes may confirm unbalanced translocations or ring chromosomes, and the study of parental karyotypes may identify familial rearrangements contributing to miscarriage. Some limitations should be acknowledged in this study. First, the sample size was relatively small and isolated in one center. Second, chromosomal abnormality was only detected by SNP array, and about 40% of cases of miscarriage could not be explained by the results of the SNP array. Therefore, further multicenter studies with larger cohorts are needed, and more techniques should be applied to find the detailed genetic causes of miscarriage. Overall, we detected chromosomal abnormalities in 336 of the 564 miscarried cases using SNP array and provided detailed chromosomal abnormalities in southern Chinese women with miscarriage. Chromosomal abnormalities, including UPD, triploidy, trisomy, and chromosomal deletions/duplications, were found. SNP array could delineate the causes of more than 50% of cases of miscarriage. However, about 40% of cases of miscarriage could not be explained by the results of SNP array and require further examinations with other techniques, such as whole-exome sequencing and whole-genome sequencing. Conclusions In 564 miscarriages, 59.6% of miscarriages were found with chromosomal aberrations, while 40% of miscarriages could not be explained by chromosomal variants using SNP array. Abbreviations Single-nucleotide polymorphism Chromosome Analysis Suite Copy number variations Variations of unknown significance Online Mendelian Inheritance in Man Database of Genomic Variants Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources Author contributions HW designed the study, performed the data analysis, and wrote the manuscript. WZ and BL collected the samples and did the SNP arrays. HH revised the manuscript. NL and LX supervised the work. Funding This work was supported by Joint Funds for the innovation of science and Technology, Fujian province (Grant number: 2023Y9360). Data availability The datasets used and/or analyzed during the current study available in The National Center for Biotechnology Information (NCBI) gene expression omnibus (GEO) GSE207887 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE207887). Declarations Conflict of interest The authors declare no competing interests. Ethical approval and consent to participate This study was approved by the ethics committee of Fujian Maternal and Child Health Hospital (ID: 2024KY139). All patients provided written informed consent for data collection, and all methods were performed in accordance with the relevant guidelines and regulations. Consent for publication Not applicable. Informed consent Informed consent was obtained from all individual participants included in the study. Footnotes Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Wantong Zhao, Haiwei Wang, and Bin Liang have contributed equally to this work and share first authorship. Contributor Information Haiwei Wang, Email: hwwang@sibs.ac.cn. Na Lin, Email: linna1088@fjmu.edu.cn. Liangpu Xu, Email: xiliangpu@fjmu.edu.cn. References Associated Data Data Availability Statement The datasets used and/or analyzed during the current study available in The National Center for Biotechnology Information (NCBI) gene expression omnibus (GEO) GSE207887 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE207887).